Skip to content

Clinical trials

Mucopolysaccharidosis II trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis II Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20084
20095
20101
20112
20121
20131
20146
20154
20173
20182
20191
20202
20213
20226
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Active, not recruiting9
Terminated8
Enrolling by invitation3
Recruiting3
Withdrawn3
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire13
REGENXBIO Inc.6
Denali Therapeutics Inc.4
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center3
Takeda3
Duke University2
JCR Pharmaceuticals Co., Ltd.2
Joanne Kurtzberg, MD2
Masonic Cancer Center, University of Minnesota2
Sangamo Therapeutics2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II51
Sudden Infant Death27
Mucopolysaccharidosis I17
Mucopolysaccharidoses13
Mucopolysaccharidosis VI13
Lysosomal Storage Diseases11
Leukodystrophy, Globoid Cell8
Leukodystrophy, Metachromatic8
Mucopolysaccharidosis III6
Mucopolysaccharidosis VII6

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.